19:41 , Jun 2, 2017 |  BioCentury  |  Product Development

Ears wide open

Based on unmet need alone, hearing loss should have been every bit as attractive to investors and drug developers as ophthalmic diseases, which entered a renaissance in the mid-2000s resulting in a multibillion-dollar market for...
08:00 , Feb 4, 2010 |  BC Innovations  |  Cover Story

Revoking serotonin's auto license

Although the majority of marketed antidepressants are designed to boost low levels of the neurotransmitter serotonin in the brain-a well-known cause of depression-only a third of patients actually respond to the first drug they are...